Abstract
The purpose of this study was to develop a sensitive and rapid method for the determination of venlafaxine in human saliva. Blank saliva samples were obtained from healthy volunteers. Their extraction was carried out on SPE columns. Cartridges of the columns were washed with water and the adsorbate was eluted with methanol. The eluate was evaporated and the residue was dissolved in a mixture of acetonitrile and water (50:50, v/v). Venlafaxine was analyzed on a HPLC system with UV detection at 226 nm. The mobile phase was a mixture of acetonitrile and a phosphate buffer (30:70 v/v) at a flow rate of 1 mL min–1. Linearity of the calibration curve was obtained in the range of 1–1000 ng mL–1 of venlafaxine in saliva. The limit of detection was 1 ng mL–1 (S/N = 3) and the limit of quantification was 3 ng mL–1 (S/N = 10). The RSD values for intra–day study varied between 0.21 and 1.67% and those for inter–day study did not exceed 8.14%. The developed method was applied to the analysis of saliva samples without interference peaks and enabled determination of the venlafaxine concentration in depressed persons. The method can be useful for controlling intake of the drug by patients.
Keywords: Venlafaxine, human saliva, HPLC, SPE
Current Pharmaceutical Analysis
Title:Determination of Venlafaxine in Human Saliva by HPLC using Solid– Phase Extraction
Volume: 9 Issue: 2
Author(s): Ewelina Dziurkowska and Marek Wesolowski
Affiliation:
Keywords: Venlafaxine, human saliva, HPLC, SPE
Abstract: The purpose of this study was to develop a sensitive and rapid method for the determination of venlafaxine in human saliva. Blank saliva samples were obtained from healthy volunteers. Their extraction was carried out on SPE columns. Cartridges of the columns were washed with water and the adsorbate was eluted with methanol. The eluate was evaporated and the residue was dissolved in a mixture of acetonitrile and water (50:50, v/v). Venlafaxine was analyzed on a HPLC system with UV detection at 226 nm. The mobile phase was a mixture of acetonitrile and a phosphate buffer (30:70 v/v) at a flow rate of 1 mL min–1. Linearity of the calibration curve was obtained in the range of 1–1000 ng mL–1 of venlafaxine in saliva. The limit of detection was 1 ng mL–1 (S/N = 3) and the limit of quantification was 3 ng mL–1 (S/N = 10). The RSD values for intra–day study varied between 0.21 and 1.67% and those for inter–day study did not exceed 8.14%. The developed method was applied to the analysis of saliva samples without interference peaks and enabled determination of the venlafaxine concentration in depressed persons. The method can be useful for controlling intake of the drug by patients.
Export Options
About this article
Cite this article as:
Dziurkowska Ewelina and Wesolowski Marek, Determination of Venlafaxine in Human Saliva by HPLC using Solid– Phase Extraction, Current Pharmaceutical Analysis 2013; 9 (2) . https://dx.doi.org/10.2174/1573412911309020006
DOI https://dx.doi.org/10.2174/1573412911309020006 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Methods to Explore Marine Resources for Alzheimers Therapeutics
Current Alzheimer Research Editorial:Genomics and Epigenomics of Tumor and Aging Cells
Current Genomics Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157
Current Pharmaceutical Design The “Entourage Effect”: Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders
Current Neuropharmacology A Glycemic Threshold of 90 mg/dl Promotes Early Signs of Atherosclerosis in Apparetly Healthy Overweight/Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Prodrug Strategies for Antihypertensives
Current Topics in Medicinal Chemistry Recent Advances in Health Promoting Effect of Dietary Polyphenols
Current Nutrition & Food Science MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14
Current Neurovascular Research Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome
CNS & Neurological Disorders - Drug Targets Cannabinoid Receptors and Endocannabinoids: Role in Neuroinflammatory and Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Vascular Reactions of Iodinated X-Ray Contrast Media: Mechanisms and Possible Therapeutic Interventions
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Efficient Synthesis of Fused Pyrimidine Derivatives with Biological Activity via Aza-Wittig Reaction
Current Organic Synthesis Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
Current Topics in Medicinal Chemistry Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Opioid Receptor-Like 1 (ORL1) Molecular “Road Map” to Understanding Ligand Interaction and Selectivity
Current Topics in Medicinal Chemistry Capillary Electrophoresis–Mass Spectrometry in Metabolomics: The Potential for Driving Drug Discovery and Development
Current Drug Metabolism Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice
CNS & Neurological Disorders - Drug Targets The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry